INBX · CIK 0002007919 · FY2025 live · 2025-12-31
Inhibrx Biosciences, Inc.
View as
Model
Classic Z
FY2025
−4.54
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−4.54
Z″ −7.18
Score −4.54 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.681.2 × = 0.81X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−1.681.4 × = −2.35X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.923.3 × = −3.04X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.060.6 × = 0.03X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.011 × = 0.01
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Inhibrx Biosciences, Inc. is on classic Z at −4.54 (distress) for FY2025, from an SEC 10-K. EBIT / assets is the line that sets the print; retained earnings / assets is the runner-up. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 32nd percentile in Healthcare.
- QCLSDistressQ/C TECHNOLOGIES, INC.−4.57
- IRWDDistressIRONWOOD PHARMACEUTICALS INC−4.48
- RAREDistressUltragenyx Pharmaceutical Inc.−4.44
- AQSTDistressAquestive Therapeutics, Inc.−4.43
- RLMDDistressRELMADA THERAPEUTICS, INC.−4.43
- CTMXDistressCytomX Therapeutics, Inc.−4.66
- ANNXDistressAnnexon, Inc.−4.41
- TILDistressInstil Bio, Inc.−4.41
KPI widgets
Current assets
$133M
Total assets
$146M
Current liabilities
$34M
Total liabilities
$138M
Working capital
$99M
Retained earnings
−$246M
EBIT
−$135M
Total sales
$1M
Book equity
$8M
Accession 0002007919-26-000006. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.